Walleye Capital LLC Mirati Therapeutics, Inc. Call Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $16,796 - $24,952	400 New	400 $23,000
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $155,359 - $212,807	4,300 Added 390.91%	5,400 $195,000
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $40,194 - $59,686	1,100 New	1,100 $40,000
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $366,177 - $515,120	-4,700 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $523,512 - $921,448	-8,800 Reduced 65.19%	4,700 $484,000
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $589,275 - $1.07 Million	13,500 New	13,500 $990,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.